Correlation Between Maccura Biotechnology and Shenzhen Centralcon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Maccura Biotechnology and Shenzhen Centralcon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maccura Biotechnology and Shenzhen Centralcon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Maccura Biotechnology Co and Shenzhen Centralcon Investment, you can compare the effects of market volatilities on Maccura Biotechnology and Shenzhen Centralcon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maccura Biotechnology with a short position of Shenzhen Centralcon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maccura Biotechnology and Shenzhen Centralcon.

Diversification Opportunities for Maccura Biotechnology and Shenzhen Centralcon

0.89
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Maccura and Shenzhen is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Maccura Biotechnology Co and Shenzhen Centralcon Investment in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shenzhen Centralcon and Maccura Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maccura Biotechnology Co are associated (or correlated) with Shenzhen Centralcon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shenzhen Centralcon has no effect on the direction of Maccura Biotechnology i.e., Maccura Biotechnology and Shenzhen Centralcon go up and down completely randomly.

Pair Corralation between Maccura Biotechnology and Shenzhen Centralcon

Assuming the 90 days trading horizon Maccura Biotechnology Co is expected to generate 0.68 times more return on investment than Shenzhen Centralcon. However, Maccura Biotechnology Co is 1.46 times less risky than Shenzhen Centralcon. It trades about 0.01 of its potential returns per unit of risk. Shenzhen Centralcon Investment is currently generating about -0.01 per unit of risk. If you would invest  1,462  in Maccura Biotechnology Co on September 12, 2024 and sell it today you would lose (39.00) from holding Maccura Biotechnology Co or give up 2.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Maccura Biotechnology Co  vs.  Shenzhen Centralcon Investment

 Performance 
       Timeline  
Maccura Biotechnology 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Maccura Biotechnology Co are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Maccura Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.
Shenzhen Centralcon 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Shenzhen Centralcon Investment are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shenzhen Centralcon sustained solid returns over the last few months and may actually be approaching a breakup point.

Maccura Biotechnology and Shenzhen Centralcon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Maccura Biotechnology and Shenzhen Centralcon

The main advantage of trading using opposite Maccura Biotechnology and Shenzhen Centralcon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maccura Biotechnology position performs unexpectedly, Shenzhen Centralcon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shenzhen Centralcon will offset losses from the drop in Shenzhen Centralcon's long position.
The idea behind Maccura Biotechnology Co and Shenzhen Centralcon Investment pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
CEOs Directory
Screen CEOs from public companies around the world
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments